These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3834163)

  • 21. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
    Herzig RH; Coccia PF; Strandjord SE; Warkintin PI; Cheung NK; Gordon EM; Novak L; Shina D
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):139-40. PubMed ID: 3296203
    [No Abstract]   [Full Text] [Related]  

  • 22. A phase I-II study of combination therapy with thymidine and cytosine arabinoside.
    Fram R; Major P; Egan E; Beardsley P; Rosenthal D; Kufe D
    Cancer Chemother Pharmacol; 1983; 11(1):43-7. PubMed ID: 6883625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study.
    Winkelman MD; Hines JD
    Ann Neurol; 1983 Nov; 14(5):520-7. PubMed ID: 6651239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes.
    Hiçsönmez G; Tuncer AM; Sayli T; Güler E; Cetin M; Ozbek N; Mufti GJ
    Hematol Pathol; 1995; 9(3-4):185-93. PubMed ID: 8655463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
    Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
    Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
    [No Abstract]   [Full Text] [Related]  

  • 26. [Neutropenic typhlitis: a frequently missed complication of aplasia-inducing tumor therapy with a possible association to the combination of etoposide with high-dose cytosine-arabinoside].
    Benz G; Gmür J; Gubler J
    Schweiz Med Wochenschr; 1994 Feb; 124(5):186-92. PubMed ID: 8128200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II study.
    Kern W; Schleyer E; Unterhalt M; Wörmann B; Büchner T; Hiddemann W
    Cancer; 1997 Jan; 79(1):59-68. PubMed ID: 8988727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphoma.
    Shipp MA; Takvorian RC; Canellos GP
    Am J Med; 1984 Nov; 77(5):845-50. PubMed ID: 6496539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of leukemia with cytosine arabinoside--on the intensification of remission].
    Tatsumi N; Masaoka T; Ueda Y; Senda N
    Gan No Rinsho; 1970 Jul; 16(7):706-12. PubMed ID: 5465488
    [No Abstract]   [Full Text] [Related]  

  • 30. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia.
    Karbasian-Esfahani M; Wiernik PH; Novik Y; Paietta E; Dutcher JP
    Cancer; 2004 Sep; 101(6):1414-9. PubMed ID: 15368329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose cytarabine in acute leukemia: toxicity and pharmacokinetics.
    Pommier Y; Pochat L; Marie JP; Zittoun RA
    Cancer Treat Rep; 1983 Apr; 67(4):371-3. PubMed ID: 6850654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypoplastic leukemia achieved long-term remission with low-dose cytosine arabinoside].
    Fujisawa S; Kanamori H; Noguchi T; Maruta A; Ogawa K; Sakai R; Taguchi J; Tomita N; Kodama F; Okubo T
    Rinsho Ketsueki; 1995 Jan; 36(1):56-8. PubMed ID: 7715078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of atypical leukemia].
    Mochizuki T; Sawada H; Okazaki T; Tashima M; Uchino H
    Gan To Kagaku Ryoho; 1986 May; 13(5):1816-22. PubMed ID: 3707144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology and human antitumor activity of cytosine arabinoside.
    Talley RW; O'Bryan RM; Tucker WG; Loo RV
    Cancer; 1967 May; 20(5):809-16. PubMed ID: 6071587
    [No Abstract]   [Full Text] [Related]  

  • 37. [Method of administration and inactivation of cytosine arabinoside in acute leukemia].
    Hirschmann WD; Kovacs EL; Gerecke D; Kaulen HD; Voigtmann R; Gross R
    Verh Dtsch Ges Inn Med; 1975; 81():1114-6. PubMed ID: 1229411
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cytosine arabinoside in the treatment of acute leukemia in children].
    Derulska D; Rokicka-Milewska R
    Pediatr Pol; 1975 Jun; 50(6):723-8. PubMed ID: 1169752
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the cytotoxicity of cytosine arabinoside.
    Haanen C; Muus P; Raymakers R; Drenthe-Schonk A; Salden M; Wessels J
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):120-9. PubMed ID: 3892698
    [No Abstract]   [Full Text] [Related]  

  • 40. Cerebellar toxicities associated with cytosine arabinoside: a nursing perspective.
    Conrad KJ
    Oncol Nurs Forum; 1986; 13(5):57-9. PubMed ID: 3638720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.